| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | SEMA | 1.28e-03 | 31 | 32 | 2 | PS51004 | |
| Domain | Sema | 1.28e-03 | 31 | 32 | 2 | SM00630 | |
| Domain | Semap_dom | 1.28e-03 | 31 | 32 | 2 | IPR001627 | |
| Domain | Sema | 1.28e-03 | 31 | 32 | 2 | PF01403 | |
| Domain | PSI | 2.57e-03 | 44 | 32 | 2 | IPR016201 | |
| Domain | PSI | 2.81e-03 | 46 | 32 | 2 | SM00423 | |
| Domain | CH | 5.53e-03 | 65 | 32 | 2 | SM00033 | |
| Domain | CH | 6.39e-03 | 70 | 32 | 2 | PF00307 | |
| Domain | - | 6.57e-03 | 71 | 32 | 2 | 1.10.418.10 | |
| Domain | CH | 6.93e-03 | 73 | 32 | 2 | PS50021 | |
| Domain | CH-domain | 7.30e-03 | 75 | 32 | 2 | IPR001715 | |
| Domain | - | 9.92e-03 | 261 | 32 | 3 | 1.10.238.10 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.19e-06 | 410 | 33 | 6 | 26949251 | |
| Pubmed | 2.35e-06 | 415 | 33 | 6 | 16385451 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 26887056 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 2.06e-05 | 1284 | 33 | 8 | 17353931 | |
| Pubmed | Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. | 3.13e-05 | 9 | 33 | 2 | 17881493 | |
| Pubmed | 14-3-3ε and NAV2 interact to regulate neurite outgrowth and axon elongation. | 3.91e-05 | 10 | 33 | 2 | 24161943 | |
| Pubmed | 6.02e-05 | 225 | 33 | 4 | 12168954 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 22955271 | ||
| Pubmed | 9.19e-05 | 251 | 33 | 4 | 29031500 | ||
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 1.18e-04 | 17 | 33 | 2 | 17626059 | |
| Pubmed | 1.25e-04 | 102 | 33 | 3 | 9734811 | ||
| Pubmed | Specific requirement of Gli transcription factors in Hedgehog-mediated intestinal development. | 1.48e-04 | 19 | 33 | 2 | 23645682 | |
| Pubmed | 1.56e-04 | 547 | 33 | 5 | 37267103 | ||
| Pubmed | CHD7 regulates cardiovascular development through ATP-dependent and -independent activities. | 1.64e-04 | 20 | 33 | 2 | 33127760 | |
| Pubmed | 2.29e-04 | 125 | 33 | 3 | 29467281 | ||
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 2.38e-04 | 24 | 33 | 2 | 28893946 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.75e-04 | 148 | 33 | 3 | 32538781 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.80e-04 | 364 | 33 | 4 | 24778252 | |
| Pubmed | 3.98e-04 | 151 | 33 | 3 | 17043677 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 3.99e-04 | 31 | 33 | 2 | 22076636 | |
| Pubmed | 3.99e-04 | 31 | 33 | 2 | 27798109 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 4.34e-04 | 377 | 33 | 4 | 38117590 | |
| Pubmed | 4.81e-04 | 34 | 33 | 2 | 12878157 | ||
| Pubmed | 9.19e-04 | 47 | 33 | 2 | 35462405 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q21 | 3.28e-03 | 118 | 33 | 2 | chr10q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q21 | 4.65e-03 | 141 | 33 | 2 | chr12q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 7.29e-03 | 178 | 33 | 2 | chr7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 9.83e-03 | 208 | 33 | 2 | chr10q22 | |
| GeneFamily | EF-hand domain containing | 1.97e-02 | 219 | 18 | 2 | 863 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.29e-06 | 186 | 32 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.49e-06 | 187 | 32 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.24e-05 | 200 | 32 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-05 | 200 | 32 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-04 | 130 | 32 | 3 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 142 | 32 | 3 | 4ac3b285adfe80c47861943cf8c6188106cb3ba8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-04 | 148 | 32 | 3 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 160 | 32 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 160 | 32 | 3 | 68b477525eeef99430382ff0a6745cac91364bc2 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.03e-04 | 160 | 32 | 3 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 160 | 32 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.07e-04 | 161 | 32 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.18e-04 | 164 | 32 | 3 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 169 | 32 | 3 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 169 | 32 | 3 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.47e-04 | 171 | 32 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 2.47e-04 | 171 | 32 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 174 | 32 | 3 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 177 | 32 | 3 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 177 | 32 | 3 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 177 | 32 | 3 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 177 | 32 | 3 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 178 | 32 | 3 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-04 | 182 | 32 | 3 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.96e-04 | 182 | 32 | 3 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 184 | 32 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-04 | 185 | 32 | 3 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 740fd06bcd3b24e6ff2ecf8080f378afc3e95084 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 5ab43a298d23238b34e898d11decf0ad81d1b14e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.26e-04 | 188 | 32 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 3.26e-04 | 188 | 32 | 3 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-04 | 189 | 32 | 3 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.36e-04 | 190 | 32 | 3 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.41e-04 | 191 | 32 | 3 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 191 | 32 | 3 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.41e-04 | 191 | 32 | 3 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 3.46e-04 | 192 | 32 | 3 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PND03-Epithelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-04 | 192 | 32 | 3 | d8c23693f690d4d568585537bbfedda05d505b3d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 192 | 32 | 3 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | Epithelial|World / shred on cell class and cell subclass (v4) | 3.46e-04 | 192 | 32 | 3 | 13a3553d9a7c78535679d23d454c63fd08f7d218 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.46e-04 | 192 | 32 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.52e-04 | 193 | 32 | 3 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-04 | 193 | 32 | 3 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.52e-04 | 193 | 32 | 3 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-04 | 193 | 32 | 3 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-04 | 193 | 32 | 3 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-04 | 193 | 32 | 3 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 3.52e-04 | 193 | 32 | 3 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 194 | 32 | 3 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 194 | 32 | 3 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 3.57e-04 | 194 | 32 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 194 | 32 | 3 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 194 | 32 | 3 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-04 | 194 | 32 | 3 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-04 | 194 | 32 | 3 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.57e-04 | 194 | 32 | 3 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 3.57e-04 | 194 | 32 | 3 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.62e-04 | 195 | 32 | 3 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.62e-04 | 195 | 32 | 3 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.62e-04 | 195 | 32 | 3 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 195 | 32 | 3 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-04 | 196 | 32 | 3 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-04 | 197 | 32 | 3 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.73e-04 | 197 | 32 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-04 | 197 | 32 | 3 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.73e-04 | 197 | 32 | 3 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-04 | 197 | 32 | 3 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.73e-04 | 197 | 32 | 3 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.73e-04 | 197 | 32 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-04 | 197 | 32 | 3 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.73e-04 | 197 | 32 | 3 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 197 | 32 | 3 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.73e-04 | 197 | 32 | 3 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | d7e15e61b6018e4c36461c9471ee29601929925c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-04 | 198 | 32 | 3 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 3.79e-04 | 198 | 32 | 3 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.79e-04 | 198 | 32 | 3 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-04 | 198 | 32 | 3 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 3.79e-04 | 198 | 32 | 3 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-04 | 198 | 32 | 3 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.79e-04 | 198 | 32 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-04 | 198 | 32 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-04 | 198 | 32 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-04 | 198 | 32 | 3 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-04 | 198 | 32 | 3 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| Disease | attention deficit hyperactivity disorder | 5.62e-04 | 354 | 32 | 4 | EFO_0003888 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 7.01e-04 | 36 | 32 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | corpus callosum anterior volume measurement | 8.23e-04 | 39 | 32 | 2 | EFO_0010295 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.34e-03 | 447 | 32 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | smoking status measurement | 1.37e-03 | 1160 | 32 | 6 | EFO_0006527 | |
| Disease | response to cisplatin, platinum measurement | 1.52e-03 | 53 | 32 | 2 | EFO_0010154, GO_0072718 | |
| Disease | vital capacity | 1.90e-03 | 1236 | 32 | 6 | EFO_0004312 | |
| Disease | platelet-derived growth factor BB measurement | 2.00e-03 | 61 | 32 | 2 | EFO_0008264 | |
| Disease | ovarian cancer (is_marker_for) | 2.48e-03 | 68 | 32 | 2 | DOID:2394 (is_marker_for) | |
| Disease | eye color | 4.30e-03 | 90 | 32 | 2 | EFO_0003949 | |
| Disease | osteoarthritis, hip | 4.49e-03 | 92 | 32 | 2 | EFO_1000786 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 4.78e-03 | 95 | 32 | 2 | EFO_0004529, EFO_0008317, EFO_0008596 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPLHTELNRAMDNCN | 86 | Q15699 | |
| AHHDLNIDQSQCNEM | 51 | Q99996 | |
| QEQMDELLQQCFLHA | 261 | P41214 | |
| FHADMCQSQNEELQR | 531 | P43652 | |
| MCQGNRDENQSINHQ | 326 | P20073 | |
| EENSHCDANTEMQQI | 511 | Q13823 | |
| DMCVILSANQNNIDD | 921 | Q12791 | |
| SMHQQLCQELQRDNV | 681 | Q6ZRQ5 | |
| SDHNSNDLLPQECNM | 471 | Q15652 | |
| QNNNILEMHEDTFCN | 266 | Q99645 | |
| QCHEAEMTDNVNQLL | 86 | O15031 | |
| SQQELHCEDPNFNMD | 441 | Q8N9T8 | |
| HQRQLQQCDCQNSLM | 1501 | Q96BY6 | |
| SQQMESCRAEIQENH | 191 | Q49AN0 | |
| QQENGHCMDTNECIQ | 551 | Q9NQ79 | |
| QMKLCVQNSHQEARN | 146 | Q9H0L4 | |
| MAFSQVQCLDDNHVN | 1 | A6ND36 | |
| EDWCNTLMNHQNQLE | 1641 | P46939 | |
| HCSTAQQEVMADNLQ | 251 | Q86YW0 | |
| NLNSENEQLQEHCAM | 681 | Q5T2S8 | |
| NLADQCNSENNAVDM | 2206 | Q8IVL1 | |
| MCSGSIIHNLNNEQD | 341 | P03915 | |
| NHPNLNTMDEFCEQV | 711 | Q14563 | |
| HNANDCDVQNLNQES | 381 | Q96SB4 | |
| QCDANNMKHSDLNNL | 696 | Q6Q759 | |
| THNVCDERMENDQLQ | 166 | A6NJ88 | |
| DDNNHLIQCIMDSQN | 26 | Q15532 | |
| AQCESNMSELQQLQN | 871 | O94804 | |
| NDNDNDIENENCMHT | 966 | Q9Y4E8 | |
| QCQNPLFTEAEHQDM | 216 | Q99835 | |
| MNETDCNPQDLHNLT | 176 | P41732 | |
| EENEDHQMNCHNTRI | 166 | Q9UL68 | |
| ANCNLNDEHVNKMNS | 381 | Q96D46 | |
| NQLQSLQNSLECAME | 141 | Q8N987 |